Peter I Jatlow MD

Professor Emeritus of and Senior Research Scientist in Laboratory Medicine and in Psychiatry

Departments & Organizations

Yale Medical GroupNIMH Research Training Program in Childhood-onset Neuropsychiatric Disorders | Albert J. Solnit Integrated Training Program | Psychiatry: Center for Nicotine and Tobacco Use Research at Yale (CENTURY); Yale Tobacco Center of Regulatory Science | Laboratory Medicine: Clinical Chemistry

Research Interests

Clinical pharmacology of psychotropic drugs; cocaine; drugs of abuse; ethanol; nicotine dependence; more...


  • M.D., SUNY Downstate Medical Center, 1961

Selected Publications

  • Jatlow P, Toll B, Leary V, Krishnan-Sarin S,S. O’Malley SS. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug and Alcohol Dependence 2008:98: 203-209.
  • George TP, Vessicchio JC, Sacco KA Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, and Jatlow PI. A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia. Biol Psychiatry; 2008 63:1092–10968.
  • Baker J, Jatlow P, Pade P, Ramakrishnan V, McCance-Katz EF. Acute Cocaine Responses Following Cocaethylene Infusion. 2007: J Drug and Alc Abuse, 33:619-625.



Latest News


Edit Profile